A clear guide to GLP-1 receptor agonists, the class of medications behind Ozempic, Wegovy, and more. Learn what they are, how they work in the body, and how the different options compare for diabetes and weight loss.
GLP-1 Agonists
Clinical trials show dramatic variation in weight loss results among people taking GLP-1 medications like Wegovy and Mounjaro. Some patients lose 25% or more of their body weight while others see far more modest results. Understanding what drives these differences can help you set realistic expectations and take steps to improve your own outcomes.
Novo Nordisk reported slower-than-expected growth in Wegovy oral tablet prescriptions, raising questions for patients weighing pill vs. injection options. This article breaks down what's driving the slowdown, what the data actually means, and how to decide which format fits your treatment goals.
Erectile dysfunction affects millions of men, and many share overlapping risk factors with obesity and type 2 diabetes. Emerging research suggests GLP-1 medications like semaglutide may improve sexual health alongside metabolic health. Here is what the current evidence shows and what questions to bring to your doctor.
New obesity treatment guidance is pushing for dietitian-led care to work alongside GLP-1 medications like semaglutide and tirzepatide. If you're on or considering a GLP-1 drug, this shift could change how your care is structured and what to ask your provider. Here's what patients need to know.
Oral semaglutide prescriptions for Wegovy dropped for the first time, raising questions about patient preferences, cost, and effectiveness compared to injectable GLP-1s. If you're weighing your options, here's what this trend actually tells you and what questions to bring to your doctor.
Dosing errors with GLP-1 medications like semaglutide and tirzepatide are drawing increased attention from medical experts. Whether you're on a branded drug or a compounded version, getting the dose right is critical for both safety and results. Here's what you need to know to protect yourself.
Prescriptions for the oral Wegovy pill declined for the first time, raising questions about patient preferences and the real-world performance of oral GLP-1 medications. Here is what the data means for anyone weighing injectable versus pill-form options and how to make the best choice for your situation.
GLP-1 medications help millions lose weight, but some patients and researchers are asking whether that weight loss comes at the cost of muscle strength. A new study out of St. Louis is investigating this question directly. Here's what current evidence shows and what you can do about it right now.
.avif)